Radiological protection in human research ethics using a case study: toward update of the ICRP Publication 62.

International Commission on Radiological Protection dose constraint medical imaging medical research involving humans research ethics right to know social value

Journal

Journal of radiological protection : official journal of the Society for Radiological Protection
ISSN: 1361-6498
Titre abrégé: J Radiol Prot
Pays: England
ID NLM: 8809257

Informations de publication

Date de publication:
10 11 2023
Historique:
received: 24 09 2023
accepted: 19 10 2023
medline: 13 11 2023
pubmed: 20 10 2023
entrez: 19 10 2023
Statut: epublish

Résumé

The benefits of biomedical research involving humans are well recognised, along with the need for conformity to international standards of science and ethics. When human research involves radiation imaging procedures or radiotherapy, an extra level of expert review should be provided from the point of view of radiological protection. The relevant publication of the International Commission for Radiological Protection (ICRP) is now three decades old and is currently undergoing an update. This paper aims to provoke discussions on how the risks of radiation dose and the benefits of research should be assessed, using a case study of diagnostic radiology involving volunteers for whom there is no direct benefit. Further, the paper provides the current understanding of key concepts being considered for review and revision-such as the dose constraint and the novel research methods on the horizon, including radiation biology and epidemiology. The analysis revisits the perspectives described in the ICRP Publication 62, and considers the recent progress in both radiological protection ethics and medical research ethics.

Identifiants

pubmed: 37857271
doi: 10.1088/1361-6498/ad04f0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 Society for Radiological Protection. Published on behalf of SRP by IOP Publishing Limited. All rights reserved.

Auteurs

Chieko Kurihara (C)

Kanagawa Dental University, Kanagawa, Japan.

Kimberly E Applegate (KE)

Department of Radiology, University of Kentucky College of Medicine, Lexington, KY, United States of America.

Jee Hyang Jeong (JH)

Department of Neurology, Ewha Womans University School of Medicine, Seoul, Republic of Korea.

Keiichi Akahane (K)

National Institutes for Quantum Science and Technology, Chiba, Japan.

Keon Wook Kang (KW)

Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH